Skip to content

NeuroOne Medical Technologies Corporation: 10-Q filed 2020-08-13

What NeuroOne Medical Technologies Corporation reported in its quarterly report filed 2020-08-13 (fiscal Q3 2020): 32 published measures, 90 facts as tagged in accession 0001213900-20-021898.

This filing

Form
10-Q (quarterly report)
Filed
2020-08-13
Fiscal period
fiscal Q3 2020
Accession
0001213900-20-021898 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NeuroOne Medical Technologies Corporation filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-06-304,462,463USD
At 2019-09-30532,615USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-06-308,389,245USD
At 2019-09-301,770,193USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-06-30-3,926,782USD
At 2020-03-31-5,185,183USD
At 2019-12-31-4,612,332USD
At 2019-09-30-1,237,578USD
At 2019-06-30-273,397USD
At 2019-03-31444,631USD
At 2018-12-31-4,958,032USD
At 2018-09-30-4,395,892USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-06-303,823,957USD
At 2019-09-30260,749USD
At 2019-06-301,246,806USD
At 2018-09-3013,260USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-7,091,060USD91
2019-10-01 to 2020-06-30-13,073,768USD274
2019-04-01 to 2019-06-30-1,862,947USD91
2018-10-01 to 2019-06-30-5,427,661USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-10-01 to 2020-06-30-3,697,970USD274
2018-10-01 to 2019-06-30-4,253,039USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-10-01 to 2020-06-3066,068USD274
2018-10-01 to 2019-06-30118,952USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-10-01 to 2020-06-307,327,246USD274
2018-10-01 to 2019-06-305,605,537USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-10-01 to 2020-06-30-66,068USD274
2018-10-01 to 2019-06-30-118,952USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-06-30-30,312,639USD
At 2019-09-30-17,238,871USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-06-30100,989USD
At 2019-09-3052,026USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-1,593,493USD91
2019-10-01 to 2020-06-30-4,784,836USD274
2019-04-01 to 2019-06-30-1,862,947USD91
2018-10-01 to 2019-06-30-4,459,894USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-06-303,904,122USD
At 2019-09-30301,751USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2020-06-308,036,500USD
At 2019-09-301,770,193USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-06-30911,481USD
At 2019-09-301,152,472USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2020-06-30162,101USD
At 2019-09-30178,838USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-04-01 to 2020-06-301,593,493USD91
2019-10-01 to 2020-06-304,784,836USD274
2019-04-01 to 2019-06-301,862,947USD91
2018-10-01 to 2019-06-304,459,894USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2020-04-01 to 2020-06-30447,154USD91
2019-10-01 to 2020-06-301,291,075USD274
2019-04-01 to 2019-06-30422,781USD91
2018-10-01 to 2019-06-301,068,260USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-06-3018,239,597shares
At 2019-09-3013,493,705shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-06-3026,367,617USD
At 2019-09-3015,987,799USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2020-06-30295,251USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2020-06-30325,784USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2020-06-30124,420USD
At 2019-09-3058,352USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2020-06-3023,431USD
At 2019-09-306,326USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2020-06-30162,101USD
At 2019-09-30178,838USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2020-06-30397,450USD
At 2019-09-30617,721USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-7,091,060USD91
2019-10-01 to 2020-06-30-13,073,768USD274
2019-04-01 to 2019-06-30-1,862,947USD91
2018-10-01 to 2019-06-30-5,427,661USD273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2020-04-01 to 2020-06-30-7,091,060USD91
2020-01-01 to 2020-03-31-1,345,642USD91
2019-10-01 to 2019-12-31-4,637,066USD92
2019-04-01 to 2019-06-30-1,862,947USD91
2019-01-01 to 2019-03-31-2,211,890USD90
2018-10-01 to 2018-12-31-1,352,824USD92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2020-04-01 to 2020-06-301,146,339USD91
2019-10-01 to 2020-06-303,493,761USD274
2019-04-01 to 2019-06-301,440,166USD91
2018-10-01 to 2019-06-303,391,634USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2020-04-01 to 2020-06-307,298USD91
2019-10-01 to 2020-06-3017,105USD274
2019-04-01 to 2019-06-30694USD91
2018-10-01 to 2019-06-30694USD273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2019-10-01 to 2020-06-3033,842USD274
2018-10-01 to 2019-06-3016,627USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2020-04-01 to 2020-06-305,579USD91
2019-10-01 to 2020-06-3016,737USD274
2019-04-01 to 2019-06-305,311USD91
2018-10-01 to 2019-06-3015,933USD273

Inspect the source

Entity
NeuroOne Medical Technologies Corporation / CIK 0001500198
Captured
2026-09-20T09:11:29.314Z
SEC response SHA-256
dec08ad6d59f8d84b3a6db4a6ff83df3a276b794fed82089495b0788055433dd

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001500198.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))